Synopsis of recent research by authors named "Naoko Mato"
- Naoko Mato's recent research primarily focuses on lung cancer, exploring resistance mechanisms to targeted therapies, such as RET inhibitors, and developing innovative treatment strategies that address mitochondrial dysfunction in non-small cell lung cancer (NSCLC).
- The research includes advancements in patient-derived models, such as patient-derived spheroids and organoids, to simulate lung cancer evolution and inform therapeutic responses, highlighting the value of personalized medicine in oncology.
- Additionally, Mato has investigated clinical implications of severe COVID-19, specifically the occurrence of delayed post-hypoxic leukoencephalopathy and its management, showcasing a commitment to understanding long-term effects of viral infections on neurological health.